CNAT

Conatus Pharmaceuticals Inc. Ownership Summary

$6.78
*  
0.55
 negative 
8.83%
Get CNAT Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Institutional Ownership

Shares Outstanding

Shares Outstanding


Institutional Summary

Total Number of Holders 42
% of Shares Outstanding 37.56%
Total Shares Held 5,871,375
Total Value of Holdings 36,578,666
Net Activity 338,669
View CNAT Ownership

Insider Trades

Buy/Sell Total Trades

Buys / Sells /Total Trades


Insider Trades Summary

Trade Type Last 3 Mo. Last 12 Mo.
Number of Buys 4 30
Number of Sells 2 8
Total Insider Trades 6 38
Net Activity (2,595,412) 13,373,173

Top 5 Insider Trades

ABERDARE GP III, L.L.C. 2,036,780
KLINGENSTEIN PAUL H 2,036,780
ADVENT VENTURE PARTNERS LLP 1,907,314
MALIK SHAHZAD 1,907,314
ABERDARE GP III, L.L.C. 1,350,439
View CNAT Insider Trades


CNAT Ownership Overview:

Conatus Pharmaceuticals Inc. (CNAT) Ownership Summary provides a snapshot of institutional holdings and activity for a particular stock. The institutional holdings summary data encompasses the holdings and change from most recent 13F filings. The insider filer data counts the number of monthly positions over 3 month and 12 month time spans. Summary data is calculated daily, using the most up to date information available.


info  Learn more about the Ownership Summary Page